Bulletin 2009/07 - European Patent Office
Bulletin 2009/07 - European Patent Office
Bulletin 2009/07 - European Patent Office
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
(C<strong>07</strong>K) I.1(1)<br />
(21) <strong>07</strong>719936.2 (22) 08.06.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) CA 20<strong>07</strong>/001020 08.06.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/140619 20<strong>07</strong>/50 13.12.20<strong>07</strong><br />
(30) 08.06.2006 US 811766 P<br />
(54) • DERIVATISIERTE INSULINOLIGOMERE<br />
• DERIVATIZED INSULIN OLIGOMERS<br />
• OLIGOMÈRES D'INSULINE DÉRIVÉS<br />
(71) Diabecore Medical Inc., 120 Eglington Ave<br />
E., Toronto ON M4P 1E2, CA<br />
(72) LOUGHEED, William D., Toronto, Ontario<br />
M5N 1H6, CA<br />
(74) Swinkels, Bart Willem, Nederlandsch<br />
Octrooibureau J. W. Frisolaan 13, 2517 JS<br />
Den Haag, NL<br />
C<strong>07</strong>K 14/705 → (51) C<strong>07</strong>K 16/28<br />
C<strong>07</strong>K 14/705 → (51) C12N 15/13<br />
C<strong>07</strong>K 14/78 → (51) C<strong>07</strong>K 14/47<br />
C<strong>07</strong>K 16/00 → (51) C08G 63/00<br />
C<strong>07</strong>K 16/00 → (51) C12N 15/13<br />
C<strong>07</strong>K 16/00 → (51) G01N 33/53<br />
C<strong>07</strong>K 16/12 → (51) C<strong>07</strong>K 14/305<br />
C<strong>07</strong>K 16/18 → (51) A61K 39/395<br />
(51) C<strong>07</strong>K 16/26 (11) 2 021 369 A2*<br />
C<strong>07</strong>K 14/58 G01N 33/74<br />
(25) En (26) En<br />
(21) <strong>07</strong>73<strong>07</strong>85.8 (22) 25.05.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) FI 20<strong>07</strong>/050298 25.05.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/138163 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />
(30) 26.05.2006 US 808695 P<br />
(54) • ANTIKÖRPER UND STANDARD FÜR NT-<br />
PROBNP- UND PROBNP-IMMUNOASSAYS<br />
• ANTIBODIES AND STANDARD FOR NT-<br />
PROBNP AND PROBNP IMMUNOASSAYS<br />
• ANTICORPS ET NORME POUR IMMU-<br />
NOESSAIS DESTINÉS À LA DÉTECTION<br />
DES MARQUEURS NT-proBNP ET proBNP<br />
(71) Hytest Ltd., Intelligate, 6th Floor Joukahaisenkatu<br />
6, 20520 Turku, FI<br />
Katrukha, Alexei, G., Napaturunkatu 3 E 32,<br />
20610 Turku, FI<br />
Seferyan, Karina R., Akademika Koroleva st.<br />
26, r, 40, Moscow 127427, RU<br />
Semenov, Alexander G., Malahitovaya st. 21,<br />
r. 40, Moscow 129128, RU<br />
Tamm, Natalia N., Kosmodamianskaya<br />
naberegnaya st. 4/22 B. r. 63, Moscow<br />
115035, RU<br />
Filatov, Vladimir L., Akademika Kapici st. 30,<br />
r. 121, Moscow 117647, RU<br />
(72) KATRUKHA, Alexei, G., Turku 20610, FI<br />
SEFERYAN, Karina, R., Moscow 127427, RU<br />
SEMENOV, Alexander, G., Moscow 129128,<br />
RU<br />
TAMM, Natalia, N., Moscow 115035, RU<br />
FILATOV, Vladimir, L., Moscow 117647, RU<br />
(74) Karvinen, Leena Maria, Oy Jalo Ant-Wuorinen<br />
Ab Iso Roobertinkatu 4-6 A, 00120<br />
Helsinki, FI<br />
(51) C<strong>07</strong>K 16/28 (11) 2 021 370 A1*<br />
C12P 21/08 A61K 39/395<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
A61P 35/00<br />
(25) En (26) En<br />
(21) <strong>07</strong>721026.8 (22) 29.04.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) CN 20<strong>07</strong>/001453 29.04.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/128231 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />
(30) 30.04.2006 CN 200610<strong>07</strong>9301<br />
06.03.20<strong>07</strong> CN 200610109138<br />
(54) • AN DEN TRAIL-REZEPTOR BINDENDE<br />
MITTEL UND DEREN VERWENDUNG<br />
• TRAIL RECEPTOR-BINDING AGENTS AND<br />
USES OF THE SAME<br />
• AGENTS DE LIAISON DU RÉCEPTEUR<br />
TRAIL ET LEURS UTILISATIONS<br />
(71) Beijing Cotimes Biotech, Ltd., Room 210,<br />
Tower B No. 12 Hongda North Road Beijing<br />
Econimic Techn. Dev. Area, Beijing 100176,<br />
CN<br />
(72) YU, Zheng, Beijing 100176, CN<br />
ZHOU, Min, Beijing 100176, CN<br />
SHEN, Enyun, Beijing 100176, CN<br />
JIA, Xianzhao, Beijing 100<strong>07</strong>0, CN<br />
SONG, Yang, Beijing 100<strong>07</strong>0, CN<br />
(74) Duckworth, Timothy John, J.A. Kemp & Co.,<br />
14 South Square, Gray's Inn, London WC1R<br />
5JJ, GB<br />
(51) C<strong>07</strong>K 16/28 (11) 2 021 371 A2*<br />
G01N 33/53 C12N 15/13<br />
(25) En (26) En<br />
(21) <strong>07</strong>756163.7 (22) 27.04.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) US 20<strong>07</strong>/010466 27.04.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/127476 20<strong>07</strong>/45 08.11.20<strong>07</strong><br />
(88) 13.03.2008<br />
(30) 28.04.2006 US 795900 P<br />
(54) • FÜR ENDOKRINE, EXOKRINE ODER DUK-<br />
TALE PANKREASZELLEN SPEZIFISCHE<br />
MONOKLONALE ANTIKÖRPER<br />
• MONOCLONAL ANTIBODIES SPECIFIC<br />
FOR PANCREATIC ENDOCRINE, EXOCRINE<br />
OR DUCTAL CELLS<br />
• ANTICORPS MONOCLONAUX SPECIFI-<br />
QUES POUR LES CELLULES PANCREATI-<br />
QUES ENDOCRINES, EXOCRINES OU<br />
DUCTALES<br />
(71) Oregon Health and Science University, <strong>Office</strong><br />
of Technology & Research Collaborations<br />
2525 SW First Avenue Suite 120, Portland,<br />
OR 97201, US<br />
(72) GROMPE, Markus, Portland, OR 97239, US<br />
STREETER, Philip, R., Oregon City, OR<br />
97045, US<br />
DORRELL, Craig, Portland, OR 97209, US<br />
ABRAHAM, Stephanie, L., Clancy, Montana<br />
59634, US<br />
LANXON-COOKSON, Kelsea, M., Oregon<br />
City, OR 97045, US<br />
(74) Gowshall, Jonathan Vallance, Forrester &<br />
Boehmert Pettenkoferstrasse 20-22, 80336<br />
München, DE<br />
(51) C<strong>07</strong>K 16/28 (11) 2 021 372 A2*<br />
C<strong>07</strong>K 14/705 A61K 39/395<br />
A61P 35/00 A61P 37/00<br />
(25) En (26) En<br />
(21) <strong>07</strong>840179.1 (22) 14.05.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
91<br />
Anmeldungen<br />
Applications<br />
Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />
(86) US 20<strong>07</strong>/068904 14.05.20<strong>07</strong><br />
(87) WO 2008/005621 2008/02 10.01.2008<br />
(88) 27.03.2008<br />
(30) 12.05.2006 US 799967 P<br />
(54) • ZUSAMMENSETZUNGEN UND VERFAH-<br />
REN ZUR MODULATION VON IMMUN-<br />
SYSTEMREAKTIONEN<br />
• COMPOSITIONS AND METHODS FOR<br />
MODULATING IMMUNE RESPONSES<br />
• COMPOSITIONS ET PROCÉDÉS DE<br />
MODULATION DE RÉPONSES IMMUNES<br />
(71) ZymoGenetics, Inc., 1201 Eastlake Avenue<br />
East, Seattle, WA 98102, US<br />
(72) LEVIN, Steven D., Seattle, Washington<br />
98115, US<br />
RAMSDELL, Frederick J., Bainbridge Island,<br />
Washington 98110, US<br />
GAO, Zeren, Redmond, Washington 98053,<br />
US<br />
HOWARD, Edward D., Seattle, Washington<br />
98144, US<br />
TAFT, David W., Kirkland, Washington<br />
98034, US<br />
JOHNSTON, Janet V., Seattle, Washington<br />
981<strong>07</strong>, US<br />
RIXON, Mark W., Issaquah, Washington<br />
98029, US<br />
HEBB, LuAnne, Seattle, Washington 98118,<br />
US<br />
(74) Tombling, Adrian George, Withers & Rogers<br />
LLP Goldings House 2 Hays Lane, London<br />
SE1 2HW, GB<br />
C<strong>07</strong>K 16/40 → (51) C12N 9/64<br />
C<strong>07</strong>K 16/40 → (51) C12N 15/53<br />
(51) C<strong>07</strong>K 16/46 (11) 2 021 373 A1*<br />
(25) En (26) En<br />
(21) <strong>07</strong>746794.2 (22) 31.05.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) KR 20<strong>07</strong>/002647 31.05.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/139359 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />
(30) 31.05.2006 US 803521 P<br />
(54) • VCAM-1-SPEZIFISCHER MONOKLONALER<br />
ANTIKÖRPER<br />
• VCAM-1 SPECIFIC MONOCLONAL ANTI-<br />
BODY<br />
• ANTICORPS MONOCLONAL VCAM-1 SPÉ-<br />
CIFIQUE<br />
(71) Hanwa Chemical Corporation, Hanwa Bldg.,<br />
1 Janggyo-dong, Jung-gu, Seoul 100-797,<br />
KR<br />
(72) CHUNG, Junho, Gyeongsangbuk-do 791-<br />
754, KR<br />
LEE, Ji Eun, Gyeonggi-do 412-748, KR<br />
RYU, Eun Kyung, Seoul 140-133, KR<br />
LEE, Sukmook, Seoul 130-867, KR<br />
(74) Bassil, Nicholas Charles, et al, Kilburn &<br />
Strode 20 Red Lion Street, London WC1R<br />
4PJ, GB<br />
(51) C<strong>07</strong>K 17/02 (11) 2 021 374 A1*<br />
C<strong>07</strong>K 17/14 G01N 33/543<br />
C12N 11/02 C12N 11/14<br />
A61K 47/48 C12Q 1/68<br />
(25) En (26) En<br />
(21) <strong>07</strong>724940.7 (22) <strong>07</strong>.05.20<strong>07</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) EP 20<strong>07</strong>/004016 <strong>07</strong>.05.20<strong>07</strong><br />
(87) WO 20<strong>07</strong>/128550 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />
(30) 05.05.2006 EP 06009343
Change language